The major factors driving the growth of this market include the large number of awareness campaigns/conferences arranged by both public and private organizations, increasing adoption of patient warming and cooling systems in developing countries, and geographic expansions undertaken by key players in the global intravascular temperature management market.
The global intravascular temperature management market is estimated to reach USD 272.3 Million by 2022 from USD 228.4 Million in 2017, at a CAGR of 3.6%.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219608793
Intravascular warming to hold the largest market share during the forecast period
On the basis of type, the intravascular temperature management market is segmented into intravascular warming and intravascular cooling. In 2017, the intravascular warming segment is expected to account for the largest share of the market. Intravascular warming systems allow the infusion of heat into the patient’s body to maintain normothermia. Intravascular warming is the fastest way of warming a patient‘s body, and plays a vital role in neurocritical care. The largest share of this segment can be attributed the increasing adoption of intravascular warming in surgical procedures.
The traumatic brain injury (TBI) segment is expected to grow at the highest rate during the forecast period
Based on medical condition, the global intravascular cooling market is classified into cardiac arrest, traumatic brain injury (TBI), stroke (bleeding & thrombosis), myocardial infarction, fever/infection and other medical conditions. The TBI segment is expected to grow at the highest CAGR during the forecast period. Intravascular cooling techniques are being used as a preventive measure to reduce intracranial pressure (ICP) during TBI treatments. As a result, the adoption of invasive cooling technology in neurocritical care units is on the rise.
North America dominated the intravascular temperature management market in 2017
North America is expected to hold the largest market share of the intravascular temperature management market in 2017, followed by Europe. The North American region is also expected to grow at the highest CAGR during the forecast period. Factors such as the increasing number of surgical centers, high incidence of cardiac arrests and neurological disorders, and the high adoption rate of technologically advanced devices in North American countries are driving the growth of the intravascular temperature management market in the region.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=219608793
Key Players:
Key players in the intravascular temperature management market include 3M (US), Smiths (UK), ZOLL Medical (US), The 37Company (Netherlands), Belmont Instrument (US), Biegler (Austria), Stihler Electronic (Germany), and BD company (US).
Key Factors Driving Growth in Enteral Feeding Devices Market: The market has evolved significantly owing to various technological advancements, such as programming and safety features in feeding pumps as well as user-friendly and portable feeding pumps.
Factors such as rising healthcare costs; surge in the number of preterm births; growth in the aging population; rising prevalence of chronic diseases such as diabetes, cancer, gastrointestinal diseases, and neurological disorders; growing awareness of enteral nutrition; and rapid improvements in healthcare facilities in emerging countries are expected to further drive the market during the forecast period.
Growing Demand for Enteral Feeding in the Home Care Sector 3.
Increasing Prevalence of Chronic Diseases Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global Enteral Feeding Devices market?
The oncology segment accounted for the largest share of the global market.
The increase in the prevalence of various types of cancers, especially head and neck cancers, cancers of the gastrointestinal system, lung cancer, and liver cancer, is expected to play a major role in the higher adoption of enteral feeding devices used to provide clinical nutrition to cancer patients.
The Pen Needles Market is expected to reach $1.8 billion by 2024 from an estimated $1.1 billion in 2019, at a CAGR of 10.8% during the forecast period.The study involved four major activities in estimating the current market size for pen needles.
The next step was to validate these findings, assumptions, and market sizing with industry experts across the value chain through primary research.Secondary Research:In the secondary research process, various secondary sources such as the WHO, International Diabetes Federation, World Bank, Global Burden of Disease Study, Food and Drug Administration, American Diabetes Association, American Association of Diabetes Educators, Centers for Disease Control and Prevention, Diabetes Canada, Statistics Canada, European Association for the Study of Diabetes, European Society of Endocrinology, Diabetes UK, National Health Service, OECD Health Statistics, Asian Association for the Study of Diabetes, ASEAN Federation of Endocrine Societies.Primary Research:In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report.
The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the pen needles market.Download PDF (Please share your specific interest to serve you better.
): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=75948613Market Segmentation:On the basis of therapy, the pen needles market is segmented into insulin, GLP-1, growth hormone, and other therapies such as osteoporosis, fertility, and obesity.
The insulin therapy segment is expected to grow at a higher CAGR during the forecast period primarily due to the high and growing diabetic population globally.
Since pen needles need to be replaced after every injection, the rising use of insulin pens is a major factor driving the demand for pen needles.
KD Market Insights (KDMI) has announced the addition of a new syndicated Market research report on the Global Medical Case Management Service Market.
This research report presents comprehensive Market dynamics including growth drivers, industry trends, Market opportunities & barriers.
The report provides Market assessment for a period of 2019-2025, with 2019 as the base year, 2020 as an estimated year and 2020-2025 as forecast period.
The Market study also presents quantitative information such as Market size, Market share, year on year growth, Market increment, compound annual growth rate (CAGR), and Market growth opportunity.Get Sample Report: https://www.kdmarketinsights.com/sample/6390KDMI study Medical Case Management Service Market also provides information on the competitive landscape which profiles major companies engaged in the Medical Case Management Service Market.
Insights presented in the report will aid readers to understand how the Medical Case Management Service Market will unfold in the years ahead.
The Market study is significant for industry stakeholders in the Medical Case Management Service Market, such as Medical Case Management Service manufacturers, raw material suppliers, distributors, and investors, and assist them in developing key business strategies for gaining share in the Market.
(Albany, US) DelveInsight has launched a new report on "Neurofibromatosis 2 Market Insights, Epidemiology, and Market Forecast-2030".DelveInsight's " Neurofibromatosis 2 Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Neurofibromatosis 2 , historical and forecasted epidemiology as well as the Neurofibromatosis 2 market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.Some of Neurofibromatosis type 2 Facts:As per National Organization for Rare Disorders, the estimated incidence of NF2 is 1 in 33,000 people worldwide.
The average age of onset is 18 to 24 years.
[2018]According to Children’s Tumor Foundation, most people develop symptoms in the late teen and early adult years, although about 10% of people develop symptoms during late childhood.Request for Free Sample Report: https://www.delveinsight.com/sample-request/neurofibromatosis-2-marketView Report: https://www.delveinsight.com/report-store/neurofibromatosis-2-marketScope of the ReportThe report covers the descriptive overview of Neurofibromatosis 2 , explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapiesComprehensive insight has been provided into the Neurofibromatosis 2 epidemiology and treatment in the 7MMAdditionally, an all-inclusive account of both the current and emerging therapies for Neurofibromatosis 2 are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscapeA detailed review of Neurofibromatosis 2 market; historical and forecasted is included in the report, covering drug outreach in the 7MMThe report provides an edge while developing business strategies, by understanding trends shaping and driving the global Neurofibromatosis 2 marketRequest for Free Sample Report: https://www.delveinsight.com/sample-request/neurofibromatosis-2-marketView Report: https://www.delveinsight.com/report-store/neurofibromatosis-2-marketNeurofibromatosis type 2 (NF2) is a rare genetic disorder characterized by the growth of non- cancerous tumors in the nervous system.
These growths develop along the nerve that carries information from the inner ear to the brain (the auditory nerve).
The NF2 gene provides instructions for making a protein called merlin (also known as schwannomin).
Merlin surrounds and insulate nerve cells (neurons) in the brain and spinal cord.
The increasing demand for miniaturized connectors, expanding medical devices industry, surging aging population, and rising prevalence of chronic diseases are some of the major reasons behind for the prosperity of the medical connectors market.
In 2016, the market attained a size of $1.9 billion, and it is projected to generate a revenue of $2.8 billion by 2023, progressing at a CAGR of 6.3% during the forecast period (2017–2023).
Medical connectors are used to latch or un-latch the tubing in medical devices and connect such devices and systems for transferring signals, data, media or power.Receive Sample Copy of this Report:https://www.psmarketresearch.com/market-analysis/medical-connector-market/report-sampleBased on product, the medical connectors market is broadly categorized into board-to-board, push-pull, radio-frequency, input/output (I/O) rectangular, and disposable plastic.
Out of these, in 2016, board-to-board connectors dominated the market with a revenue contribution of $725.8 million, and these are predicted to continue dominating it during the forecast period.
This is attributed to the fact that these connectors comply with strict safety standards, such as prevention of inadvertent plug disengagement, and have a better shock rating.Make an Enquiry before Purchase:https://www.psmarketresearch.com/send-enquiry?enquiry-url=medical-connector-marketSimilarly, as per the World Bank, in 2012, in the U.S., 30,537 surgeries were done per 100,000 population.
In 2015, the number of surgical procedures done in Australia was 28,907 per 100,000 population.
